Kornder, Nele, Baum, Erika, Maisel, Peter et al. · ZFA. Zeitschrift fur Allgemeinmedizin · 2023 · DOI
Quick Summary
This guideline helps family doctors diagnose and treat fatigue by providing a systematic approach. When fatigue has no clear cause, doctors should ask about sleep, mood, medications, and life stressors, and perform basic blood tests. The guideline emphasizes that fatigue often has multiple causes working together, and recommends checking specifically for post-exertional malaise (PEM)—a key feature of ME/CFS—so patients can receive appropriate specialized care.
Why It Matters
This guideline is significant for ME/CFS patients because it formally integrates PEM recognition into primary care fatigue assessment, potentially reducing diagnostic delays and misclassification as purely psychiatric or behavioral conditions. For researchers, it reflects emerging consensus that ME/CFS requires specific diagnostic criteria distinct from undifferentiated fatigue, improving case identification and clinical heterogeneity management in epidemiological and intervention studies.
Observed Findings
Fatigue is one of the most common reasons for primary care consultation with frequent diagnostic uncertainty.
Patient descriptions of fatigue span emotional, cognitive, physical, and behavioral dimensions.
Multiple biological, psychological, and social causes often coexist in single patients.
Post-exertional malaise is identified as a key distinguishing feature requiring specific assessment.
Inferred Conclusions
Systematic screening for depression, anxiety, and post-exertional malaise should be routine in fatigue evaluation.
Basic laboratory testing (glucose, CBC, inflammation markers, liver and thyroid function) is appropriate first-line investigation in undetermined fatigue.
When PEM is present, ME/CFS-specific diagnostic criteria should be assessed and specialist management arranged.
A biopsychosocial framework improves fatigue management across multiple etiologies.
Remaining Questions
What diagnostic accuracy and clinical utility does PEM screening have in primary care for identifying ME/CFS versus other fatigue disorders?
Which patient phenotypes benefit most from behavioral therapy versus symptom-oriented activation approaches in ME/CFS specifically?
What This Study Does Not Prove
This guideline does not provide evidence for specific treatment efficacy—it is consensus-based rather than hypothesis-testing research. It does not establish causality between identified risk factors and fatigue, nor does it validate diagnostic thresholds or prove that behavioral interventions work for ME/CFS specifically (it notes they may help other fatigue causes). The guideline offers clinical procedure recommendations, not mechanistic insights into fatigue pathophysiology.